What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in Q1 2026?

3 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK for Q1 2026. Use the holders table for investor-level position and value details.

PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / COMMON STOCK
Shares outstanding: 53,185,766
Total 13F shares: 441,677
Share change: +265,602
Total reported value: $552,334
Price per share: $1.24
Number of holders: 3
Value change: +$333,800
Number of buys: 2
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
INTERWEST PARTNERS X LP	3/4/5	10%+ Owner	— class O/S missing	4,502,480	$10,040,531	—	13 Jul 2021	3/4/5
ORBIMED ADVISORS LLC	3/4/5 13F	10%+ Owner · Company	9.4%	4,975,291	$7,562,442	-$2,420,000	23 Oct 2025	3/4/5 13F
TANG CAPITAL MANAGEMENT LLC	13D/G 13F	Company	8.9%	4,720,357	$6,702,907	$0	16 Sep 2025	13D/G 13F
BML Capital Management, LLC	13F	Company	10%	5,292,000	$6,615,000	—	31 Dec 2025	13F
BML Investment Partners, L.P.	13D/G	—	9.9%	5,292,000	$6,615,000	+$2,527,616	31 Dec 2025	13D/G
ArrowMark Colorado Holdings LLC	13D/G 13F	Company	5.8%	3,090,093	$3,862,616	$0	31 Dec 2025	13D/G 13F
Sio Capital Management, LLC	13D/G 13F	Company	5%	2,636,548	$3,691,167	-$1,538,387	30 Sep 2025	13D/G 13F
Euclidean Capital LLC	13F 3/4/5	Company · 10%+ Owner	4.9%	2,627,643	$3,284,554	—	31 Dec 2025	13F 3/4/5
VANGUARD GROUP INC	13F	Company	4.1%	2,170,310	$2,712,888	—	31 Dec 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	3.8%	2,015,770	$2,518,000	—	31 Dec 2025	13F
Thilo Schroeder	3/4/5	Director	— class O/S missing	1,101,283	$2,455,861	—	06 Oct 2021	3/4/5
Stonepine Capital Management, LLC	13F	Company	2.2%	1,150,759	$1,438,449	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	2.1%	1,094,883	$1,368,605	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.6%	874,100	$1,092,625	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.3%	706,061	$882,576	—	31 Dec 2025	13F
David Henry Mack	3/4/5	President and CEO, Director	— mixed-class rows	1,253,047 mixed-class rows	$697,788	-$62,179	05 Mar 2026	3/4/5
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.99%	524,350	$655,438	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.94%	498,641	$623,301	—	31 Dec 2025	13F
Aldebaran Capital, LLC	13F	Company	0.9%	477,988	$597,485	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.87%	465,086	$581,358	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.84%	446,140	$557,802	—	31 Dec 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	428,853	$536,066	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.72%	382,088	$477,611	—	31 Dec 2025	13F
Walleye Capital LLC	13F	Company	0.63%	335,694	$419,618	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.45%	240,138	$300,173	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.34%	183,178	$228,973	—	31 Dec 2025	13F
RBF Capital, LLC	13F	Company	0.3%	162,200	$202,750	—	31 Dec 2025	13F
Assenagon Asset Management S.A.	13F	Company	0.26%	140,468	$175,585	—	31 Dec 2025	13F
EVOKE WEALTH, LLC	13F	Company	0.25%	133,122	$166,403	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.24%	127,041	$158,801	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.22%	118,593	$148,241	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.2%	104,485	$130,606	—	31 Dec 2025	13F
ADAR1 Capital Management, LLC	13F	Company	0.19%	101,008	$126,260	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.19%	98,875	$123,595	—	31 Dec 2025	13F
Ikarian Capital, LLC	13F	Company	0.17%	89,136	$111,421	—	31 Dec 2025	13F
Robert Ticktin	3/4/5	General Counsel & COO	— mixed-class rows	417,965 mixed-class rows	$105,090	-$24,651	05 Mar 2026	3/4/5
Leila Alland	3/4/5	Chief Medical Officer	— class O/S missing	45,909	$102,377	—	15 Sep 2023	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	78,784	$98,480	—	31 Dec 2025	13F
Deepika Jalota	3/4/5	Chief Development Officer	— mixed-class rows	393,269 mixed-class rows	$95,761	-$35,198	05 Mar 2026	3/4/5
Michael Carulli	3/4/5	Chief Financial Officer	— mixed-class rows	313,848 mixed-class rows	$92,310	-$30,077	05 Mar 2026	3/4/5
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.14%	73,211	$91,513	—	31 Dec 2025	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.12%	65,114	$81,392	—	31 Dec 2025	13F
Seven Fleet Capital Management LP	13F	Company	0.12%	63,498	$79,373	—	31 Dec 2025	13F
ALGERT GLOBAL LLC	13F	Company	0.12%	62,020	$78,000	—	31 Dec 2025	13F
Rangeley Capital, LLC	13F	Company	0.09%	45,500	$56,875	—	31 Dec 2025	13F
Velan Capital Investment Management LP	13F	Company	0.07%	35,000	$43,750	—	31 Dec 2025	13F
HSBC HOLDINGS PLC	13F	Company	0.06%	30,891	$39,386	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.05%	28,744	$35,930	—	31 Dec 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.05%	27,862	$34,827	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.05%	27,536	$34,420	—	31 Dec 2025	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q1 2026

As of 31 Mar 2026, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 441,677 shares. The largest 3 holders included Assenagon Asset Management S.A., Accurate Wealth Management, LLC, and HSBC HOLDINGS PLC. This page lists 3 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-59

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.